Finance News – Regeneron Pharmaceuticals

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Stocks Ceo Investors Shares Tariffs Stock Stock Market Crypto Assets Cryptocurrency Ethereum Price Markets Xrp Stablecoin Etf Investment Bse Blockchain Ipo Sec Eth Index Solana Trade Inflation Earnings Interest Rates Coinbase Revenue Token Sensex Wall Street Nasdaq China Federal Reserve Nse Treasury Traders Bse Sensex Gold Sp 500 Nifty Tesla Economy Profit Usd Investor Cryptocurrency Exchange Bank For International Settlements Business Owner Us Justice Department Fv Bank Force Queensland Casinos Stock Ideas Oil Explorer Car Registrations

Filter by:

Regeneron Pharmaceuticals ×

CNBC Business • May 27, 2025

23andMe to delist from Nasdaq, deregister with SEC

The planned acquisition of most 23andMe assets by Regeneron Pharmaceuticals for $256 million will result in the company's withdrawal from public stock trading and regulatory report...

Read Full Article →

The Guardian – Business • May 19, 2025

Bankrupt DNA testing firm 23andMe to be purchased for $256m

Regeneron Pharmaceuticals’ acquisition of a consumer genetic testing company for $256 million during bankruptcy highlights a significant investment in genetic data assets, promptin...

Read Full Article →

CBC Business • May 19, 2025

Bankrupt DNA testing company 23andMe to be bought by Regeneron

Regeneron’s acquisition of the financially troubled DNA testing firm could impact the handling of extensive genetic data, while addressing concerns about privacy and potential misu...

Read Full Article →